EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access

Transcatheter aortic valve implantation reduces plasma concentrations of TMAO and indoxyl sulfate: A prospective, multicenter cohort study

Aleksandra Gąsecka iD, Marcelina Gniot, Bogna Rajewska, Weronika Dykacz, Weronika Kisielewska, Ewelina Błażejowska iD, Jakub M Zimodro iD, Marcin Grabowski iD, Bartosz Rymuza, Zenon Huczek iD, Janusz Kochman iD, Radosław Wilimski iD und 7 weitere

Cardiology Journal · 2025

DOI: 10.5603/cj.102844 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cardiology Journal, 2025. Verfasst von Aleksandra Gąsecka und 18 weiteren Autor:innen. Beteiligte Einrichtung: 1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland. gaseckaa@gmail.com. Hauptthemen laut MEDLINE: Methylamines, Transcatheter Aortic Valve Replacement, Indican, Aortic Valve Stenosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intestinal microbial metabolites, such as trimethylamine-N-oxide (TMAO) and indoxyl sulfate (IS), have been suggested as markers for the progression of aortic stenosis (AS). However, the impact of transcatheter aortic valve implantation (TAVI) on these intestinal bacterial metabolites has not been evaluated in a multicenter clinical study. The aim of this study was to determine the effect of TAVI on plasma levels of intestinal bacterial metabolites and to assess the predictive value of these metabolites for major adverse cardiovascular events (MACE) following TAVI.

Methods

Consecutive patients with AS referred for TAVI were enrolled in this study. Blood samples were collected one day before TAVI and at hospital discharge. The concentrations of intestinal microbial metabolites were measured using ultra performance liquid chromatograph coupled with a mass spectrometer.

Results

Plasma levels of TMAO and IS decreased after TAVI, compared to baseline (p ≤ 0.004 for all). Among 128 patients included in the study, 21 patients (16.4%) developed MACE during the median follow-up time of 404 days. Baseline plasma IS level was higher in patients with MACE, compared to those without MACE (p = 0.001). Increased baseline IS level predicted MACE with 75.0% sensitivity and 74.3% specificity independent of other clinical variables (OR 14.264, 95% CI 3.442–59.117, p < 0.001) and decreased the chance of event-free survival (plog rank < 0.001).

Conclusions

Plasma concentrations of TMAO and IS decreased after TAVI, compared to baseline. Elevated plasma IS levels were associated with a 14-fold increase in the odds of post-TAVI MACE during a median follow-up period of 404 days.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethylaminesTranscatheter Aortic Valve ReplacementIndicanAortic Valve StenosisGastrointestinal MicrobiomeAortic ValveHumansMaleFemaleProspective StudiesBiomarkersAged, 80 and overAgedTime FactorsFollow-Up StudiesTreatment OutcomeRisk Factors

Stichwörter der Autor:innen

aortic stenosisindoxyl sulfateintestinal metabolitestranscatheter aortic valve implantationtrimethylamine-N-oxide

Substanzen

MethylaminestrimethyloxamineIndicanBiomarkers

Autor:innen und Institutionen

  • 1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland. gaseckaa@gmail.com.
  • 1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
  • Department of Cardiac Surgery, Medical University of Warsaw, Warsaw, Poland.
  • University of Zielona Góra, Collegium Medicum, Department of Interventional Cardiology and Cardiac Surgery, Zielona Góra, Poland.
  • Department of Cardiology, Nowa Sól Multidisciplinary Hospital, Nowa Sól, Poland.
  • Department of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences, Poznan, Poland.

ORCID-Profile: Aleksandra Gąsecka, Ewelina Błażejowska, Jakub M Zimodro, Marcin Grabowski, Zenon Huczek, Janusz Kochman, Radosław Wilimski, Mariusz Kuśmierczyk, Jan Budzianowski, Jarosław Hiczkiewicz, Anna Olasińska-Wiśniewska, Marek Grygier, Marcin Ufnal

Zitieren

APA

Gąsecka, A., Gniot, M., Rajewska, B., Dykacz, W., Kisielewska, W., Błażejowska, E., Zimodro, J. M., Grabowski, M., Rymuza, B., Huczek, Z., Kochman, J., Wilimski, R., Kuśmierczyk, M., Budzianowski, J., Hiczkiewicz, J., Olasińska-Wiśniewska, A., Grygier, M., Filipiak, K. J., & Ufnal, M. (2025). Transcatheter aortic valve implantation reduces plasma concentrations of TMAO and indoxyl sulfate: A prospective, multicenter cohort study. Cardiology Journal. https://doi.org/10.5603/cj.102844

Vancouver

Gąsecka A, Gniot M, Rajewska B, Dykacz W, Kisielewska W, Błażejowska E, et al. Transcatheter aortic valve implantation reduces plasma concentrations of TMAO and indoxyl sulfate: A prospective, multicenter cohort study. Cardiology Journal. 2025. doi:10.5603/cj.102844

BibTeX
@article{Gsecka2025,
  author = {Gąsecka, Aleksandra and Gniot, Marcelina and Rajewska, Bogna and Dykacz, Weronika and Kisielewska, Weronika and Błażejowska, Ewelina and Zimodro, Jakub M and Grabowski, Marcin and Rymuza, Bartosz and Huczek, Zenon and Kochman, Janusz and Wilimski, Radosław and Kuśmierczyk, Mariusz and Budzianowski, Jan and Hiczkiewicz, Jarosław and Olasińska-Wiśniewska, Anna and Grygier, Marek and Filipiak, Krzysztof J and Ufnal, Marcin},
  title = {Transcatheter aortic valve implantation reduces plasma concentrations of TMAO and indoxyl sulfate: A prospective, multicenter cohort study},
  journal = {Cardiology Journal},
  year = {2025},
  doi = {10.5603/cj.102844}
}
Kostenlos starten →